Vivo Capital, LLC Clene Inc. Transaction History

Vivo Capital, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2023 Nov 08, 2023	SELL	$0.46 - $0.87 $862,630 - $1.63 Million	-1,875,284 Reduced 41.48%	2,645,338 $1.32 Million
Q2 2023 Aug 14, 2023	BUY	$0.78 - $1.22 $3.53 Million - $5.52 Million	4,520,622 New	4,520,622 $3.98 Million

7.44M

48.1K

160K

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $21M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.